Related Experiment Videos
[Diabetic cardiac autonomic neuropathy]
J C Philips1, M Marchand, A J Scheen
1Université de Liège, Chef de Service, Service de Diabétologie, Nutrition et Maladies Métaboliques, Département de Médecine, CHU Sart Tilman. jcphilips@ulg.ac.be
Revue Medicale De Liege
|July 23, 2005
Summary
Cardiac autonomic neuropathy (CAN), a diabetes complication, increases mortality risk. This study assesses CAN using noninvasive blood pressure monitoring and a unique squatting test to evaluate baroreflex gain in diabetic patients.
Area of Science:
- Cardiology
- Endocrinology
- Autonomic Neuroscience
Context:
- Cardiac autonomic neuropathy (CAN) is a frequent complication of diabetes mellitus.
- CAN significantly elevates risks for morbidity and mortality in diabetic individuals.
- Accurate assessment of CAN is crucial for patient management and prognosis.
Purpose:
- To detail the laboratory's extensive experience in assessing CAN in diabetic patients.
- To highlight the utility of continuous, noninvasive blood pressure and heart rate monitoring using Finapres.
- To introduce and validate a discriminative active orthostatic maneuver, the "squatting" test, for CAN evaluation.
Summary:
- The study focuses on the assessment of cardiac autonomic neuropathy (CAN) in diabetic patients.
- Utilizes Finapres for continuous, noninvasive monitoring of blood pressure and heart rate.
- Employs a specialized "squatting" test (standing-squatting-standing) as an active orthostatic maneuver to assess baroreflex gain.
Impact:
- Provides a validated, noninvasive method for CAN detection in diabetes.
- Enhances understanding of baroreflex gain alterations in diabetic autonomic dysfunction.
- Contributes to improved diagnostic strategies for cardiovascular complications in diabetes mellitus.